Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Launches Analytical Services Program

NEW ORLEANS (GenomeWeb News) – Bruker announced today at Pittcon 2008 that it has launched a fee-based service for data acquisition and analysis for a wide range of scientific experiments using its full range of instruments.
 
The new offering, called Bruker Analytical Services, combines tools from the newly merged Bruker BioSciences and Bruker BioSpin, such as mass spectrometry, NMR, X-ray, FTIR, and Raman spectroscopy. It targets clients in several industries including pharmaceuticals, biotech, and petroleum, as well as academic institutions.
 
Bruker will run the experiments in its own labs. Mark Chaykovsky, executive vice president of Bruker BioSpin, said the service would provide rapid turnaround of results for customers.
 
The service was announced along with five new mass spec products including the apex-ultra FTMS, FlashFormula NALDI-TOF, next-generation EDT II, MALDI-TDS, and microTOF-Q II.
 
Frank Laukien, chairman and CEO of Bruker, said during a question-and-answer session following a press conference here that the firm would provide more information on its plans for the molecular diagnostics market during the third quarter of 2008.
 
At the time Bruker announced the acquisition of BioSpin, Laukien said, “We believe what will emerge in 2008 will be a focused molecular diagnostics division drawing on technologies and resources from various Bruker Corporation operating companies.”

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.